Candel Therapeutics, Inc.CC

Candel Therapeutics, Inc.

7.91USDR
−1.06−11.87%
At close at 00:56 GMT
USD
No trades
See on Supercharts
Back

Diluted net income available to common stockholders of Candel Therapeutics, Inc.

Annual data
2020
2021
2022
2023
TTM
‪‪−60.00 M‬‬
‪‪−45.00 M‬‬
‪‪−30.00 M‬‬
‪‪−15.00 M‬‬
‪0.00‬
Period
Value
Change
Change %
TTM
‪‪−52.20 M‬‬
‪‪−14.26 M‬‬
‪−37.59‬%
2023
‪‪−37.94 M‬‬
‪‪−19.14 M‬‬
‪−101.87‬%
2022
‪‪−18.79 M‬‬
+‪‪17.33 M‬‬
+‪47.97‬%
2021
‪‪−36.12 M‬‬
‪‪−18.44 M‬‬
‪−104.32‬%
2020
‪‪−17.68 M‬‬
‪‪−9.44 M‬‬
‪−114.56‬%
Quarterly data
Q3 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−24.00 M‬‬
‪‪−18.00 M‬‬
‪‪−12.00 M‬‬
‪‪−6.00 M‬‬
‪0.00‬
Period
Value
Change
Change %
Q3 '24
‪‪−10.65 M‬‬
+‪‪11.59 M‬‬
+‪52.12‬%
Q2 '24
‪‪−22.24 M‬‬
‪‪−14.02 M‬‬
‪−170.49‬%
Q1 '24
‪‪−8.22 M‬‬
+‪‪2.87 M‬‬
+‪25.90‬%
Q4 '23
‪‪−11.10 M‬‬
‪‪−2.66 M‬‬
‪−31.54‬%
Q3 '23
‪‪−8.44 M‬‬
+‪‪1.18 M‬‬
+‪12.26‬%
Q2 '23
‪‪−9.61 M‬‬
‪‪−819.00 K‬‬
‪−9.31‬%
Q1 '23
‪‪−8.79 M‬‬
‪‪−3.71 M‬‬
‪−73.03‬%
Q4 '22
‪‪−5.08 M‬‬
+‪‪3.60 M‬‬
+‪41.49‬%
Q3 '22
Q2 '22
Q1 '22
Q4 '21
Q3 '21
Q2 '21
Q1 '21
Q3 '20